NGAL: An Upcoming Biomarker of Interest

Aim: Neutrophil gelatinase-associated lipocalin (NGAL) performs important functions in the body. It has the potential to act as a diagnostic and prognostic biomarker for various diseases. Background: The role of NGAL has been well explored in acute and chronic kidney diseases (CKDs). It is considere...

Full description

Saved in:
Bibliographic Details
Main Authors: Khushboo Jasotani, Kiran Dahiya, Raunak Ahlawat, Mohit Gupta, Sushil Kumar, Rakesh Dhankhar, Pragati Singh
Format: Article
Language:English
Published: Jaypee Brothers Medical Publisher 2023-01-01
Series:Indian Journal of Medical Biochemistry
Subjects:
Online Access:https://www.ijmb.in/doi/IJMB/pdf/10.5005/jp-journals-10054-0206
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850182198328557568
author Khushboo Jasotani
Kiran Dahiya
Raunak Ahlawat
Mohit Gupta
Sushil Kumar
Rakesh Dhankhar
Pragati Singh
author_facet Khushboo Jasotani
Kiran Dahiya
Raunak Ahlawat
Mohit Gupta
Sushil Kumar
Rakesh Dhankhar
Pragati Singh
author_sort Khushboo Jasotani
collection DOAJ
description Aim: Neutrophil gelatinase-associated lipocalin (NGAL) performs important functions in the body. It has the potential to act as a diagnostic and prognostic biomarker for various diseases. Background: The role of NGAL has been well explored in acute and chronic kidney diseases (CKDs). It is considered a maker for acute kidney injury (AKI). Its role in other diseases has also been increasingly reported. Results: Neutrophil gelatinase-associated lipocalin takes part in the pathogenesis of several diseases, besides renal diseases, like cardiovascular diseases, inflammatory disorders, cancer, diabetes, etc. by a variety of mechanisms. Its levels have been correlated with the severity in most of the diseases. Conclusion: Neutrophil gelatinase-associated lipocalin can act as a biomarker in different diseases though, its potential is yet to be explored to the maximum. Clinical significance: Estimating the levels of NGAL in body fluids will help in making an early diagnosis, assessing the severity of the disease, establishing a prognosis, and improving the overall management of different diseases.
format Article
id doaj-art-1eaabcdc641545d98b9c3795441d5f9f
institution OA Journals
issn 0972-1207
2456-5164
language English
publishDate 2023-01-01
publisher Jaypee Brothers Medical Publisher
record_format Article
series Indian Journal of Medical Biochemistry
spelling doaj-art-1eaabcdc641545d98b9c3795441d5f9f2025-08-20T02:17:41ZengJaypee Brothers Medical PublisherIndian Journal of Medical Biochemistry0972-12072456-51642023-01-01261263010.5005/jp-journals-10054-02065NGAL: An Upcoming Biomarker of InterestKhushboo Jasotani0Kiran Dahiya1Raunak Ahlawat2Mohit Gupta3Sushil Kumar4Rakesh Dhankhar5Pragati Singh6Department of Biochemistry, Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana, IndiaKiran Dahiya, Department of Biochemistry, Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India, Phone: +91 9896111985Department of Pathology, Maulana Azad Medical College, New Delhi, IndiaDepartment of Cardiothoracic Surgery, National Heart Institute, New Delhi, IndiaDepartment of Biochemistry, NC Medical College & Hospital, Panipat, Haryana, IndiaDepartment of Radiation Oncology, Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana, IndiaDepartment of Biochemistry, Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana, IndiaAim: Neutrophil gelatinase-associated lipocalin (NGAL) performs important functions in the body. It has the potential to act as a diagnostic and prognostic biomarker for various diseases. Background: The role of NGAL has been well explored in acute and chronic kidney diseases (CKDs). It is considered a maker for acute kidney injury (AKI). Its role in other diseases has also been increasingly reported. Results: Neutrophil gelatinase-associated lipocalin takes part in the pathogenesis of several diseases, besides renal diseases, like cardiovascular diseases, inflammatory disorders, cancer, diabetes, etc. by a variety of mechanisms. Its levels have been correlated with the severity in most of the diseases. Conclusion: Neutrophil gelatinase-associated lipocalin can act as a biomarker in different diseases though, its potential is yet to be explored to the maximum. Clinical significance: Estimating the levels of NGAL in body fluids will help in making an early diagnosis, assessing the severity of the disease, establishing a prognosis, and improving the overall management of different diseases.https://www.ijmb.in/doi/IJMB/pdf/10.5005/jp-journals-10054-0206biomarkerdiseasesneutrophil gelatinase-associated lipocalinlipocalins
spellingShingle Khushboo Jasotani
Kiran Dahiya
Raunak Ahlawat
Mohit Gupta
Sushil Kumar
Rakesh Dhankhar
Pragati Singh
NGAL: An Upcoming Biomarker of Interest
Indian Journal of Medical Biochemistry
biomarker
diseases
neutrophil gelatinase-associated lipocalin
lipocalins
title NGAL: An Upcoming Biomarker of Interest
title_full NGAL: An Upcoming Biomarker of Interest
title_fullStr NGAL: An Upcoming Biomarker of Interest
title_full_unstemmed NGAL: An Upcoming Biomarker of Interest
title_short NGAL: An Upcoming Biomarker of Interest
title_sort ngal an upcoming biomarker of interest
topic biomarker
diseases
neutrophil gelatinase-associated lipocalin
lipocalins
url https://www.ijmb.in/doi/IJMB/pdf/10.5005/jp-journals-10054-0206
work_keys_str_mv AT khushboojasotani ngalanupcomingbiomarkerofinterest
AT kirandahiya ngalanupcomingbiomarkerofinterest
AT raunakahlawat ngalanupcomingbiomarkerofinterest
AT mohitgupta ngalanupcomingbiomarkerofinterest
AT sushilkumar ngalanupcomingbiomarkerofinterest
AT rakeshdhankhar ngalanupcomingbiomarkerofinterest
AT pragatisingh ngalanupcomingbiomarkerofinterest